US Patent 8946163 Cross-linked collagen comprising metallic anticancer agents
Patent 8946163 was granted and assigned to MIMEDX GROUP, INC. on February, 2015 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 8946163 Cross-linked collagen comprising metallic anticancer agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
